M
Moses R. Kamya
Researcher at Makerere University
Publications - 504
Citations - 15407
Moses R. Kamya is an academic researcher from Makerere University. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 60, co-authored 435 publications receiving 12598 citations. Previous affiliations of Moses R. Kamya include Mulago Hospital.
Papers
More filters
Journal ArticleDOI
Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study.
Carol S. Camlin,Catherine A. Koss,Monica Getahun,Lawrence Owino,Harriet Itiakorit,Cecilia Akatukwasa,Irene Maeri,Robert Bakanoma,Anjeline Onyango,Frederick Atwine,James Ayieko,Jane Kabami,Florence Mwangwa,Mucunguzi Atukunda,Asiphas Owaraganise,Dalsone Kwarisiima,Norton Sang,Elizabeth A. Bukusi,Moses R. Kamya,Maya L. Petersen,Craig R. Cohen,Edwin D. Charlebois,Diane V. Havlir +22 more
TL;DR: Delivery models that promote youth access, frame messaging on wellness and goals, and foster partner and peer support, may facilitate uptake among young people.
Journal ArticleDOI
The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda
TL;DR: Investigation of the impact of age, baseline temperature, and pre-treatment parasite density on estimates of treatment efficacy using a statistical modeling approach in 2,138 patients enrolled in six clinical trials involving seven different treatment regimens found that enrolling only patients fulfilling selection criteria recommended by the World Health Organization increased the risk of treatment failure by 25-60%.
Journal ArticleDOI
Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in uganda
Nathan Bakyaita,Grant Dorsey,Adoke Yeka,Kristin Banek,Sarah G. Staedke,Moses R. Kamya,Ambrose Talisuna,Fred Kironde,Sam L. Nsobya,Albert Kilian,Arthur Reingold,Philip J. Rosenthal,Fred Wabwire-Mangen +12 more
TL;DR: The use of combinations of inexpensive drugs for the treatment of malaria in Africa has been proposed as an interim policy while awaiting the widespread availability of more effective regimens, but existing levels of resistance raises concern about the useful therapeutic life-span of this regimen.
Journal ArticleDOI
Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation
TL;DR: Suboptimal adherence to benzathine penicillin injections was associated with incident heart failure and mortality over 1 year in participants with established RHD in Uganda, which was higher than in recently published from other low and middle income countries.
Journal ArticleDOI
Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance
Anne Gasasira,Moses R. Kamya,Edwin O Ochong,Neil M. Vora,Jane Achan,Edwin D. Charlebois,Theodore Ruel,Fredrick Kateera,Denise N Meya,Diane V. Havlir,Philip J. Rosenthal,Grant Dorsey +11 more
TL;DR: Despite high prevalence of known anti-folate resistance-mediating mutations, TS prophylaxis was highly effective against malaria, but was associated with presence of dhfr 164L mutation.